Remus Pharmaceuticals Limited (NSE:REMUS)
India
· Delayed Price · Currency is INR 878.55
-11.25 (-1.26%)
At close: Jul 10, 2025
Remus Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
Net Income | 290.7 | 215.37 | 85.03 | 34.34 | 10.26 | Upgrade
|
Depreciation & Amortization | 18.7 | 8.73 | 4.64 | 1.55 | 1.75 | Upgrade
|
Other Amortization | - | 0.23 | 0.13 | - | - | Upgrade
|
Loss (Gain) From Sale of Assets | -2.1 | - | - | - | - | Upgrade
|
Other Operating Activities | 93.9 | 20.53 | -3.93 | -1.72 | -0.66 | Upgrade
|
Change in Accounts Receivable | 72.6 | -471.36 | -19.33 | 6.89 | -19.77 | Upgrade
|
Change in Inventory | -84.4 | -6.21 | 13.02 | -4.39 | -7.14 | Upgrade
|
Change in Accounts Payable | -219.3 | 362.16 | -15.07 | 14.97 | 48.01 | Upgrade
|
Change in Other Net Operating Assets | -100.3 | -93.43 | -11.36 | -1.26 | -4.07 | Upgrade
|
Operating Cash Flow | 69.8 | 36.02 | 53.13 | 50.38 | 28.38 | Upgrade
|
Operating Cash Flow Growth | 93.76% | -32.20% | 5.46% | 77.52% | 117.86% | Upgrade
|
Capital Expenditures | -111.2 | -6.36 | -27.32 | -0.71 | -0.66 | Upgrade
|
Sale of Property, Plant & Equipment | 3 | - | - | - | - | Upgrade
|
Cash Acquisitions | - | -93.37 | - | - | - | Upgrade
|
Investment in Securities | 2.7 | -5.91 | -175.48 | -30.01 | -0.67 | Upgrade
|
Other Investing Activities | 28.9 | 22.35 | 3.45 | 2.44 | 0.69 | Upgrade
|
Investing Cash Flow | -105.5 | -89.43 | -151.92 | -45.45 | -30.9 | Upgrade
|
Short-Term Debt Issued | 89.3 | - | - | - | - | Upgrade
|
Long-Term Debt Issued | 3.3 | - | 77.51 | - | - | Upgrade
|
Total Debt Issued | 92.6 | - | 77.51 | - | - | Upgrade
|
Long-Term Debt Repaid | -5.1 | -65.03 | - | -0.87 | -0.8 | Upgrade
|
Net Debt Issued (Repaid) | 87.5 | -65.03 | 77.51 | -0.87 | -0.8 | Upgrade
|
Issuance of Common Stock | - | 476.85 | 42.5 | - | - | Upgrade
|
Common Dividends Paid | -11.8 | -5.89 | - | - | - | Upgrade
|
Other Financing Activities | -15 | -162.27 | -2.33 | -0.87 | -0.35 | Upgrade
|
Financing Cash Flow | 60.7 | 243.66 | 117.69 | -1.74 | -1.15 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | 0 | - | 0 | Upgrade
|
Net Cash Flow | 25 | 190.26 | 18.9 | 3.18 | -3.68 | Upgrade
|
Free Cash Flow | -41.4 | 29.67 | 25.81 | 49.67 | 27.72 | Upgrade
|
Free Cash Flow Growth | - | 14.93% | -48.03% | 79.21% | 272.81% | Upgrade
|
Free Cash Flow Margin | -0.67% | 1.39% | 5.72% | 20.09% | 14.74% | Upgrade
|
Free Cash Flow Per Share | -4.64 | 2.62 | 3.16 | 6.21 | 3.46 | Upgrade
|
Cash Interest Paid | - | 4.84 | 2.33 | 0.87 | 0.35 | Upgrade
|
Cash Income Tax Paid | 14.6 | 65.66 | 29.97 | 11.94 | 3.65 | Upgrade
|
Levered Free Cash Flow | -530 | -210.09 | 7.45 | 42.87 | 24.7 | Upgrade
|
Unlevered Free Cash Flow | -520.88 | -207.29 | 8.73 | 43.36 | 24.88 | Upgrade
|
Change in Net Working Capital | 702.25 | 384.67 | 35.43 | -16.11 | -16.53 | Upgrade
|
Updated Nov 9, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.